Novonesis A/s Class B · OMXCOP:NSIS_B
Novonesis A/s Class B — Q1 2025 Earnings Presentation
14 slides from Novonesis A/s Class B's earnings presentation, May 8, 2025
Slide 1: Q1 2025 Conference Call
Q1 2025 _ Conference Call
Slide 2: Forward-looking statement
Forward-looking statement Disclaimer This presentation includes forward-looking statements, including statements relating to the operating, financial and sustainability performance and results of the group and/or the industry in which it operates. Forward-looking statements include, without limitati
Slide 3: Strong start to the year, full-year outlook confirmed
Strong start to the year, full-year outlook Sales and organic sales growth y/y 44% 56% confirmed Food & Health Biosolutions Planetary Health EURm Biosolutions • Organic sales growth (OSG) of 11% • Volume growth (~10%) supported by pricing (~1%) +11% OSG • Emerging markets grew 15%; developed markets
Slide 4: Food & Health Biosolutions
Human Health Sales and organic sales growth, 26% Food & Health Biosolutions y/y Food & Health Biosolutions 74% EURm +12% Food & Beverages OSG Performance Q1 2025 • Organic sales growth of 12% 424.8 476.4 • Growth supported by both Food & Beverages and Human Health Q1 2024 Q1 2025 • Growth mainly dri
Slide 5: Food & Health Biosolutions: Food & Beverages
Sales and organic sales growth Food & Health Biosolutions: Food & Beverages y/y Food & Beverages EURm +11% OSG Performance Q1 2025 • Organic sales growth of 11% 352.7 317.4 • Broad-based growth across geographies and industries • Strong momentum in Dairy supported by innovation Q1 2024 Q1 2025 • Pos
Slide 6: Food & Health Biosolutions: Human Health
Sales and organic sales growth Human Health y/y Food & Health Biosolutions: Human Health EURm +13% OSG Performance Q1 2025 • Organic sales growth of 13% 123.7 107.4 • Strong growth in Dietary Supplements • Advanced Health & Nutrition driven by Advanced Protein Solutions (APS); Early Life Nutrition s
Slide 7: Planetary Health Biosolutions
Household Care Sales and organic sales growth 36% Planetary Health Biosolutions y/y Planetary Health Biosolutions 64% EURm Agriculture, Energy & Tech +11% OSG Performance Q1 2025 • Organic sales growth of 11% 540.7 601.2 • Growth supported by both Household Care and Agriculture, Energy & Tech Q1 202
Slide 8: Planetary Health Biosolutions: Household Care
Sales and organic sales growth Household Care y/y Planetary Health Biosolutions: Household Care EURm +12% OSG Performance Q1 2025 • Organic sales growth of 12% 191.9 215.5 • Strong growth driven by accelerated penetration in emerging markets as well as strong performance in developed markets, suppor
Slide 9: Planetary Health Biosolutions: Agriculture, Energy & Tech
Sales and organic sales growth Agriculture, Energy & Tech y/y Planetary Health Biosolutions: Agriculture, Energy & Tech EURm +10% OSG Performance Q1 2025 • Organic sales growth of 10% 385.7 348.8 • Strong growth in Energy and Tech • Growth in Agriculture driven by Plant Q1 2024 Q1 2025 • Positive im
Slide 10: Financial results Q1 2025
Financial results Q1 2025 – 11% broad-based organic sales growth – 310 bps improvement in Adj. EBITDA margin driven by stronger adjusted gross margin and synergies – 27% increase in adj. EPS and 36% in adj. EPS excl. PPA – Cash flow benefitted from higher net profit, offset by lower trade payables a
Slide 11: Outlook 2025
Outlook 2025 • Organic sales growth of 5-8% (6-9% excl. exiting certain countries) • 4-7 % volume • ~ 1 % price • ~ 1 % sales synergies • ~ (1) % exiting certain countries • Adjusted EBITDA margin between 37 and 38% Outlook 2025¹ Organic sales growth 5-8% (6-9% excl. exit) Adjusted EBITDA margin 37-
Slide 12: Summary
Summary • Strong Q1 performance across the business • 2025 outlook maintained • Well positioned despite higher macro-related uncertainty 12
Slide 13: Q&A
Q&A
Slide 14: Organic sales performance by region
Organic sales performance by region North America Developed markets Q1 y/y: +7% Q1 y/y: +9% Europe, the Middle East & Africa Q1 y/y: +14% 64% 32% of sales of sales 37% of sales Asia Pacific Latin America Q1 y/y: +9% Emerging markets Q1 y/y: +18% Q1 y/y: +15% 12% 19% 36% of sales of sales of sales 14